Observational Study of Iris Tumors

Conditions

• Iris Tumor

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Accepted

Study Details

This is an observational study using OCT angiography to assist with tumor characterization in melanotic and amelanotic iris lesions. OCT angiography data from healthy eyes will be compared to eyes with various types of iris tumors.

Key Dates

Start date

Jun 20, 2018

Status verified

Sep 2025

Primary completion

Dec 31, 2026

Completion

Dec 31, 2027

Study Design

Enrollment

100 participants (estimated)

Arms

• Arm: Iris Tumors
  This group will consist of 50 adults age 18 or older who have been diagnosed with either melanotic or amelanotic iris tumors. Iris tumor diagnosis will be confirmed by biopsy when possible or based upon clinical features (if patient declines biopsy or if not medically indicated) according to standard-of-care guidelines.
• Arm: Healthy Controls
  This group will consist of 50 adults age 18 and older who have healthy eyes.

Primary Outcome Measure

Tumor Thickness in Benign vs Malignant Iris Lesions [ Time Frame: 6 months ]

Central Contacts

• Denzil Romfh, OD
  503-494-4351
  [email protected]
• Humberto Martinez, COT
  503-494-7712
  [email protected]

Locations (1)

Find similar trials in Portland, OR